Document is current
Any future updates will be listed below
-
Authors
Oshika, Tetsuro
Arai, Hiroyuki
Fujita, Yoshifumi
Inamura, Mikio
Inoue, Yasushi
Noda, Toru
Miyata, Kazunori
- License Information
-
More Information
Article History
Received: 3 January 2019
Accepted: 27 August 2019
First Online: 11 September 2019
Competing Interests
: All authors received research support from Santen Pharmaceutical for this clinical trial. Dr. Tetsuro Oshika received compensation as a consultant from Alcon, Johnson & Johnson Vision, Santen Pharmaceutical, and Mitsubishi Tanabe. He receives research support from Santen Pharmaceutical, Tomey, Alcon, Senju Pharmaceutical, Johnson & Johnson Vision, HOYA, KOWA Pharmaceutical, Otsuka Pharmaceutical, Novartis, Pfizer, and Topcon. Dr. Yasushi Inoue receives research support from Santen Pharmaceutical. Dr. Kazunori Miyata receives research support from Santen Pharmaceutical, GlaxoSmithKline, Alcon, Senju Pharmaceutical, Sucampo Pharmaceutical, Otsuka Pharmaceutical, Becton Dickinson, Novartis, Johnson & Johnson Vision, and HOYA.
